Big Island boy battles insurer for mainland treatment approval

Big Island families who need advanced care often hit the same wall: the doctor is not on island, the flight is not cheap, and the approval can take longer than a child’s condition can wait. For 11-year-old Paul Gugger, that wall became a fight over whether his insurer would authorize specialized treatment on the mainland U.S.

Paul, a Hawaii Island boy, had been diagnosed with Ehlers-Danlos syndrome, a rare genetic connective-tissue disorder, along with a series of other medical problems that left him sick to his stomach. His case stood out because the conditions were unusual enough that Hawaii News Now described them as affecting only a small number of diagnosed patients, underscoring how medically complex his situation had become.

His parents were fighting their insurance company for approval to seek care outside Hawaii. On Hawaii Island, that kind of dispute carried heavy consequences. Many advanced services were unavailable locally, forcing patients to travel to Oahu or farther for specialists. The island also faced long-running provider shortages and transportation barriers, which made every referral harder to complete and every delay more damaging.

That burden fell especially hard on families dealing with rare diseases. Mayo Clinic says Ehlers-Danlos syndrome is uncommon and can be difficult to diagnose and treat because it takes a doctor with experience in the disorder. When expertise was concentrated off-island, even a routine referral could turn into a logistical and financial strain, with families juggling flights, appointments and the uncertainty of whether care would be approved in time.

The Gugger case put a face on a broader access problem that has shadowed Hawaii Island for years. Communities are spread across a large island, specialist appointments are often centered on Honolulu, and patients can lose precious time while trying to connect with doctors across the water. For Paul and his family, the fight over approval was not just about one child’s rare illness. It was about whether distance, cost and paperwork would stand between a Big Island family and the treatment their son needed.